SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001424884-13-000037
Filing Date
2013-08-19
Accepted
2013-08-19 16:41:25
Documents
9
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 form10qa.htm 10-Q/A 958746
2 exhibit31-1.htm EX-31.1 13924
3 exhibit32-1.htm EX-32.1 5218
  Complete submission text file 0001424884-13-000037.txt   5793759

Data Files

Seq Description Document Type Size
4 tpiv-20130331.xml EX-101.INS 392618
5 tpiv-20130331.xsd EX-101.SCH 46759
6 tpiv-20130331_cal.xml EX-101.CAL 16086
7 tpiv-20130331_def.xml EX-101.DEF 12428
8 tpiv-20130331_lab.xml EX-101.LAB 221628
9 tpiv-20130331_pre.xml EX-101.PRE 139513
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-27239 | Film No.: 131048679
SIC: 2834 Pharmaceutical Preparations